Delivery Order SPE2DB20D6035-SPE2DB24FD1XD
- Not listed
- This federal contract award, valued at $2,127.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,568,143,281 units of Dextroamphetamine-Amphetamine 10 mg capsules. The contract is a Firm Fixed Price Delivery Order with a completion date of May 6, 2025. No set-aside designation was used for this award. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,694,053 units of dextroamphetamine-amphetamine 10 mg capsules in lots of 100. The contract has a ceiling value of $1,070.34 and a period of performance through March 26, 2025. It is a delivery order contract with a firm fixed price pricing type. The award is not associated with a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,237.89, is a Firm Fixed Price Delivery Order to provide 4,567,886,472 units of the prescription drug dextroamphetamine-amphetamine 10 mg capsules. The award has an ultimate completion date of April 14, 2025. This contract is not associated with a set-aside designation. Amerisourcebergen holds a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is a firm fixed price delivery order for 4,563,829,899 tablets of dextroamphetamine-amphetamine 10 mg capsules, with a potential value of $1,320.00 and a completion date of March 4, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,118.64 firm fixed-price delivery order is for the supply of 4,566,790,127 dextroamphetamine-amphetamine 10 mg capsules. The contract has an ultimate completion date of December 24, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award, valued at $5,457.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for a delivery order to supply 4,567,771,288 units of the prescription medication dextroamphetamine-amphetamine 10 mg capsules. The contract has a firm fixed price pricing type and an ultimate completion date of April 3, 2025. This award is not associated with a set-aside program and...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,888.87, is for the delivery of 4,562,349,164 units of dextroamphetamine-amphetamine 10 mg capsules. This is a firm fixed-price delivery order contract with an ultimate completion date of October 2, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
- The federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,320.00 firm-fixed-price delivery order is for the supply of 4,564,513,270 units of the prescription drug dextroamphetamine-amphetamine 10 mg capsules. This award is for a period of performance ending on May 7, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) valued up to...
- This federal contract award, valued at $3,492.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Dextroamphetamine-Amphetamine 20 mg capsules, with an ultimate completion date of April 23, 2025. The contract is a Firm Fixed Price Delivery Order, without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award, valued at $1,260.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,566,334,653 units of dextroamphetamine-amphetamine 15 mg capsules, a pharmaceutical product. The contract has an ultimate completion date of November 6, 2024 and is a Firm Fixed Price Delivery Order. The contract was not set aside for any specific business type. Amerisourcebergen Drug Corp is a...
- SPE2DB20D6035Indefinite Delivery Contract
- SPE2DB20D6035-SPE2DB24FD1XDDelivery Order
This federal contract award, valued at $2,522.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution services company Amerisourcebergen Corporation. The award is for the delivery of 4,564,035,820 units of dextroamphetamine-amphetamine 10 mg capsules in 100-count packages. The contract is a firm fixed price delivery order with a period of performance through March 21, 2024. It does not have a set-aside designation. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 3/20/24 |